Pharmaceutical Country of Origin – Tariffs
Question: Hello ICPA Membership, With recent tariffs on specific countries, have you seen guidance on if CBP will continue to view COO as the country where API was produced for generic pharma products? For example, the API supplier could be in Israel, but vials are filled and finished in China. Currently CBP says Israel is […]